The Rapid Response® COVID-19 & Influenza A/B Antigen Test Pen is an in vitro immunoassay. The assay is for the direct and qualitative detection of viral nucleocapsid proteins of SARS-CoV-2, Influenza A virus, and Influenza B virus from nasal secretions from individuals suspected of Influenza A, B or COVID-19 infection within the first 7 days of symptoms onset. This test is intended for point of care use only.
